1. Home
  2. OVID vs AXTI Comparison

OVID vs AXTI Comparison

Compare OVID & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • AXTI
  • Stock Information
  • Founded
  • OVID 2014
  • AXTI 1986
  • Country
  • OVID United States
  • AXTI United States
  • Employees
  • OVID N/A
  • AXTI N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • AXTI Semiconductors
  • Sector
  • OVID Health Care
  • AXTI Technology
  • Exchange
  • OVID Nasdaq
  • AXTI Nasdaq
  • Market Cap
  • OVID 85.2M
  • AXTI 93.9M
  • IPO Year
  • OVID 2017
  • AXTI 1998
  • Fundamental
  • Price
  • OVID $1.06
  • AXTI $1.84
  • Analyst Decision
  • OVID Strong Buy
  • AXTI Strong Buy
  • Analyst Count
  • OVID 5
  • AXTI 5
  • Target Price
  • OVID $4.04
  • AXTI $5.30
  • AVG Volume (30 Days)
  • OVID 216.9K
  • AXTI 410.4K
  • Earning Date
  • OVID 11-12-2024
  • AXTI 10-31-2024
  • Dividend Yield
  • OVID N/A
  • AXTI N/A
  • EPS Growth
  • OVID N/A
  • AXTI N/A
  • EPS
  • OVID N/A
  • AXTI N/A
  • Revenue
  • OVID $631,695.00
  • AXTI $94,685,000.00
  • Revenue This Year
  • OVID $21.51
  • AXTI $32.13
  • Revenue Next Year
  • OVID $7,300.79
  • AXTI $12.84
  • P/E Ratio
  • OVID N/A
  • AXTI N/A
  • Revenue Growth
  • OVID 113.21
  • AXTI 15.24
  • 52 Week Low
  • OVID $0.68
  • AXTI $1.82
  • 52 Week High
  • OVID $4.10
  • AXTI $5.64
  • Technical
  • Relative Strength Index (RSI)
  • OVID 37.15
  • AXTI 30.42
  • Support Level
  • OVID $1.11
  • AXTI $2.00
  • Resistance Level
  • OVID $1.47
  • AXTI $2.23
  • Average True Range (ATR)
  • OVID 0.11
  • AXTI 0.18
  • MACD
  • OVID -0.02
  • AXTI -0.05
  • Stochastic Oscillator
  • OVID 6.82
  • AXTI 1.99

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single-element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

Share on Social Networks: